As the U.S. moves into the fall, concerns about seasonal respiratory viruses and COVID-19 are resurfacing. Traditionally, respiratory virus season intensifies during the winter, but COVID-19 has disrupted these predictable patterns. Recent years have shown recurring COVID-19 surges, often peaking in August and again in January. This year followed a similar trend, with a late-summer peak in August that is now declining. Experts suggest increased summer travel and school breaks may contribute to these seasonal “blips.” Current COVID-19 indicators—including emergency department visits, test positivity rates, and deaths—are trending downward. Meanwhile, influenza has not yet emerged significantly, though early signals have appeared in parts of the Midwest and Southeast. Historically, flu activity accelerates around the holiday season, especially after Thanksgiving, when travel and gatherings increase.
The conversation also highlighted concerns about vaccine uptake. Although vaccination remains strongly recommended for older adults and vulnerable populations, enthusiasm appears to be waning among younger, healthier groups. This trend could indirectly endanger high-risk individuals, since community-level immunity plays a key role in protecting them. Studies have shown, for example, that vaccinating nursing home staff often provides more protection to residents than vaccinating residents themselves.
Looking ahead, experts warn that reduced vaccine coverage—particularly for COVID-19 and influenza—may increase pneumonia incidence and other complications among the vulnerable. While it is difficult to predict the exact trajectory of this respiratory season, the combination of evolving COVID-19 strains, shifting vaccine policies, and anticipated winter gatherings could heighten risks in the months ahead.